Now Is A Good Time To Buy Sana Biotechnology Inc (NASDAQ: SANA)

During the last session, Sana Biotechnology Inc (NASDAQ:SANA)’s traded shares were 1.83 million, with the beta value of the company hitting 1.64. At the end of the trading day, the stock’s price was $8.50, reflecting an intraday loss of -0.93% or -$0.08. The 52-week high for the SANA share is $12.00, that puts it down -41.18 from that peak though still a striking 67.76% gain since the share price plummeted to a 52-week low of $2.74. The company’s market capitalization is $1.87B, and the average trade volume was 2.00 million shares over the past three months.

Sana Biotechnology Inc (NASDAQ:SANA) trade information

Sana Biotechnology Inc (SANA) registered a -0.93% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.93% in intraday trading to $8.50, hitting a weekly high. The stock’s 5-day price performance is 9.96%, and it has moved by -10.15% in 30 days. Based on these gigs, the overall price performance for the year is 61.90%.

Sana Biotechnology Inc (SANA) estimates and forecasts

Statistics show that Sana Biotechnology Inc has outperformed its competitors in share price, compared to the industry in which it operates. Sana Biotechnology Inc (SANA) shares have gone up 185.23% during the last six months, with a year-to-date growth rate more than the industry average at 36.81% against 12.90.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -83.13%. While earnings are projected to return 18.26% in 2024.

SANA Dividends

Sana Biotechnology Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders